We believe interactions with health care professionals bring value to patient care
AbbVie is committed to collaborating with health care professionals
(HCPs), health care organizations (HCOs) and patient organizations to
improve patient health across the globe. Our interactions with HCPs,
HCOs and patient organizations are guided by openness and transparency
to ensure public trust and confidence. AbbVie supports disclosure of
these relationships wherever possible to demonstrate the integrity of
our relationships with HCPs, HCOs and
patient organizations.
HCP/HCO disclosures inside the US
Open payments—Physician Payments Sunshine Act
The US Sunshine Act, also known as the Open Payments—Physician Payments Sunshine Act, was enacted as federal law in 2010 as a component of the Affordable Care Act. The Act requires health care manufacturers, including AbbVie, to track financial transactions with certain health care providers and health care organizations (HCOs) and to disclose those transactions on an annual basis. We support the Act and its goal of providing the public greater visibility into interactions between the health care industry and HCPs to ensure public trust and confidence. To learn more, view our FAQs.
Report information
The report is based on transactional data that has been aggregated at a particular point in time; some payments and transfers of value that take place during the reporting period may be included in the next quarter’s report. Posted data may not correlate to state transparency reports due to differences in the scope and requirements between the various transparency laws. Changes or additions that are identified after the report is posted will be accounted for in the next quarter’s report. Due to the requirements for reporting related entities/payees, some payments shown on the report are included more than once. The types of payments and transfers of value included in the report are as follows:
- Business meals, which include reimbursed amounts for meals incurred in the course of providing contracted-for services such as consulting and research; and meals provided in connection with an educational or business discussion
- Business travel, which includes reimbursed amounts and the value of directly provided transportation (e.g., airfare, taxi service) incurred in the course of providing contracted-for services such as consulting and research
- Educational materials and items, which include reference materials such as journal articles, textbooks and anatomical models
-
Professional services, which include payments for
contracted-for services such as speaking at an educational seminar
or serving on a data safety monitoring board
- Research-related payments, which include payments for research and clinical trial activities, royalties and license fees
-
Job interview-related payments, such as flights, meals,
hotel, area tours, etc. Your collected information will only be
released on the public website if you are selected to interview and
have expenses paid for or reimbursed to you by AbbVie. Additionally,
Massachusetts and Vermont have expanded rulings that require
interview-related expenses to be reported for “Health Care Providers
& Practitioners.” Expenses incurred during the interview process
may be reported under the Federal Sunshine Act (and other state
laws)
For physician payment reports, AbbVie follows the annual de minimis threshold reporting guidance as provided by CMS for Open Payments reporting.
Related reports
2019 Annual Physician Payment Report
2019 Annual Supplemental Report - Indirect Research Payments Made to Entities
2018 Annual Physician Payment Report
2018
Annual Supplemental Report - Indirect Research Payments Made to
Entities
2016 Annual Supplemental Report – Indirect Research Payments Made to Entities
2015 Annual Physician Payment Report
2015 Annual Supplemental Report – Indirect Research Payments Made to Entities
2014 Annual Physician Payment Report
2014 Annual Supplemental Report – Indirect Research Payments Made to Entities
2013 Annual Physician Payment Report
2012 Annual Physician Payment Report (July 1–December 31)
If you have questions on the data contained in the reports, please email TransparencyReporting@abbvie.com.
HCP/HCO disclosures outside of the US
Information exchanged with Healthcare Professionals (HCPs),
Healthcare Organizations (HCOs) and patient organizations leads to
newer and better therapies and, most importantly, enhanced care for
patients. We believe interactions with healthcare professionals and
healthcare organizations are essential to advance patient care, gain
insights into unmet medical needs and progress the development of new
medicines. Our interactions with HCPs and HCOs are based on trust,
transparency and integrity, with a goal of providing the public with
greater visibility into these interactions to ensure public trust and
confidence. AbbVie engages in a range of activities from clinical
research to sponsorships to educational activities to exchange
information on how new medicines fit into the patient pathway. By
bringing greater transparency to these relationships, AbbVie
demonstrates its ongoing commitment to strengthening the basis for
future collaboration.